Skip to main content
Clinical Trials/NCT00446394
NCT00446394
Completed
N/A

Exercise & Health Promotion for MCI: A Controlled Trial

University of Washington1 site in 1 country181 target enrollmentJune 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
University of Washington
Enrollment
181
Locations
1
Primary Endpoint
Changes in cognitive status
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this project is to evaluate an exercise and health promotion program for older adults with mild memory loss. The study will investigate the efficacy of a memory-enhanced exercise and health promotion program to determine whether it is more effective than a social walking program in delaying further memory decline, improving mood and physical function, and enhancing quality of life.

Detailed Description

This project is a randomized controlled trial to evaluate the efficacy of a group exercise and health promotion program designed specifically for older adults with Mild Cognitive Impairment (MCI). This study builds upon previous studies designed for cognitively intact older adults, with a supplemental study using a modified intervention for MCI participants, and for individuals with Alzheimer's disease. Taken together, these prior investigations support the efficacy of behaviorally based exercise interventions in improving cognitive, physical, and affective status in cognitively intact and demented older adults. Results from a feasibility study suggest that these positive outcomes can also be obtained in older adults with MCI. The current study will investigate the efficacy of the modified exercise program called RALLI (Resources and Activities for Life Long Independence) to determine whether it is more effective than the control condition, a social walking program (SW), in delaying cognitive decline, improving self-rated health and health behaviors, improving affect and physical function, and enhancing quality of life. The long-term efficacy of RALLI to delay conversion of MCI to dementia, reduce physical disability, maintain independent living, and improve physiological health indicators will also be investigated. One hundred seventy participants over the age of 70 who meet American Academy of Neurology criteria for MCI will be recruited from independent living retirement residences. Participants will be randomly assigned to one of the two conditions (RALLI and SW) and assessed at baseline, post treatment (3 months), and follow up visits every 6 months for a total of 3 years (months 6, 12, 18, 24, 30, and 36). The hypothesis is that RALLI participants will experience better post-treatment outcomes than SW participants, and that gains will be maintained over 36 months.

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
October 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Linda Teri

Professor

University of Washington

Eligibility Criteria

Inclusion Criteria

  • Mild Cognitive Impairment defined as
  • - Memory complaint
  • - Objective memory impairment for age and education
  • - Largely intact general cognitive function
  • - Essentially preserved activities of daily living
  • - Not already diagnosed with dementia
  • Insufficient physical activity defined as less than 150 minutes per week of moderate intensity physical activity
  • Not currently in an exercise program similar to the study program

Exclusion Criteria

  • Not ambulatory
  • Expected to move from the study geographic area during the study period
  • Have a known terminal illness
  • Actively suicidal, hallucinating, or delusional
  • Hospitalized for a psychiatric disorder in the 12 months before baseline
  • Uncontrolled chronic conditions, e.g. uncontrolled hypertension, unstable angina, uncontrolled blood glucose
  • Blind or deaf

Outcomes

Primary Outcomes

Changes in cognitive status

Time Frame: baseline, 3, 6, 12, 18, 24, 30, and 36 months

Secondary Outcomes

  • Changes in health, affective, and functional status(baseline, 3, 6, 12, 18, 24, 30, and 36 months)

Study Sites (1)

Loading locations...

Similar Trials